Literature DB >> 15728436

Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat.

Kerry A Waters1, Katherine E Burnham, Desmond O'connor, Gerard R Dawson, Rebecca Dias.   

Abstract

It is well known that modafinil is an effective wake-promoting agent, but there is growing evidence to suggest that modafinil may also enhance some aspects of cognition. In man, modafinil has been shown to enhance vigilance in sleep-deprived and/or narcoleptic subjects and also to improve executive-type functioning (predominantly inhibitory response control processes) across a variety of human patient population groups. Preclinically, a delay-dependent improvement has been reported with modafinil in a mouse T-maze test of working memory. To investigate further the role of modafinil as a potential cognition enhancer, the effects of modafinil on attentional processes were assessed in the rat. The aim of the present study was to evaluate the potential of modafinil to enhance five-choice serial reaction time test (5-CSRT) performance. Lister Hooded rats received 32-128 mg/kg modafinil and 5-CSRT performance was assessed under standard and test parametric conditions in which the attentional load was increased, and also under conditions of scopolamine pre-treatment. Modafinil failed to significantly enhance 5-CSRT performance under standard conditions. Similarly, modafinil was unable to reverse the deficits in accuracy and/or increased omission errors induced by either parametric or pharmacological manipulations. Indeed, at higher doses, modafinil caused an increase in premature responding under certain test conditions, suggestive of increased impulsivity. The present findings suggest that, although modafinil may enhance vigilance in sleep-deprived human subjects, attentional processes in normal awake rats remain unaffected. No evidence was found to support a modafinil-induced improvement in response control; rather, under conditions of increased attentional load, modafinil appeared to facilitate impulsive responding. Finally, the failure of modafinil to improve a scopolamine-induced performance deficit suggests that modafinil does not act on the cholinergic system directly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728436     DOI: 10.1177/0269881105048995

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  30 in total

1.  Stress modulation of the memory retrograde-enhancing effects of the awakening drug modafinil in mice.

Authors:  Daniel Béracochéa; Pierrette Liscia; Christophe Tronche; Frédéric Chauveau; Jean-Claude Jouanin; Christophe Piérard
Journal:  Psychopharmacology (Berl)       Date:  2007-10-13       Impact factor: 4.530

Review 2.  The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks.

Authors:  Dawn M Eagle; Andrea Bari; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

3.  Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity.

Authors:  Neil Dawson; Rhiannon J Thompson; Allan McVie; David M Thomson; Brian J Morris; Judith A Pratt
Journal:  Schizophr Bull       Date:  2010-09-01       Impact factor: 9.306

4.  Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model.

Authors:  Pascal Jean Denis Goetghebeur; Linda Lerdrup; Anders Sylvest; Rebecca Dias
Journal:  Psychopharmacology (Berl)       Date:  2010-08-24       Impact factor: 4.530

5.  Wake-promoting agent modafinil worsened attentional performance following REM sleep deprivation in a young-adult rat model of 5-choice serial reaction time task.

Authors:  Yia-Ping Liu; Che-Se Tung; Yu-Lung Lin; Chia-Hsin Chuang
Journal:  Psychopharmacology (Berl)       Date:  2010-09-24       Impact factor: 4.530

6.  Modafinil prevents inhibitory avoidance memory deficit induced by sleep deprivation in rats.

Authors:  Karin Monteiro Moreira; Tatiana Lima Ferreira; Debora Cristina Hipolide; Raquel Vecchio Fornari; Sergio Tufik; Maria Gabriela Menezes Oliveira
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

7.  Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.

Authors:  John P Redrobe; Lisbeth Elster; Kristen Frederiksen; Christoffer Bundgaard; Inge E M de Jong; Garrick P Smith; Anne Techau Bruun; Peter H Larsen; Michael Didriksen
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

Review 8.  The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.

Authors:  Catharine A Winstanley
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 9.  Pharmacological enhancement of memory and executive functioning in laboratory animals.

Authors:  Stan B Floresco; James D Jentsch
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

Review 10.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.